NEUROPSYCHIATRY and BEHAVIORAL NEUROLOGY | PSYCHOPHARMACOLOGY
FORENSICS | RESEARCH | CONSCIOUSNESS | PHILOSOPHY | BOOKS | LITERATURE
PERSPECTIVES | CLINICAL | DÉJÀ VU | INTERESTING AREAS | ETHICS | CONTACT

KEY ARTICLES: CONSCIOUSNESS | DOUBLE BLIND | HEAD INJURY | NARCOLEPSY | PAROXYSMAL DISORDERS | PRESCRIPTION PRINCIPLES | TARDIVE DYSKINESIA

Enduring Interest: Generic Substitution | Genius | Groundbreaking Paradigm Shifts | Zmail

Dr. Neppe on:

Attorney medical expert selection

Closed Head Injury

Buspirone and Attention Deficit Disorder

Buspirone and Agggression

Cry the Beloved Mind (Neppe psychopharmacology book)

Dr. Vernon Neppe's Bio on JurisPro

Dr. Vernon Neppe's Bio on ExpertWitness

Ethics

Neuropsychiatry

Psychopharmacology

Forensic Links

Lawsonline.com

Lawchek.com

Interesting Perspectives

SOBIN ---- Subtle Organic Brain Inventory of Neppe

The SOBIN is a special screening instrument developed in November 2002 by Vernon M Neppe, MD, PhD at the Pacific Neuropsychiatric Institute in Seattle.


The test has five major purposes:
  • To elicit soft organic brain pathology which is particularly important in neuropsychiatric cases. This allows for eliciting such phenomena as prosopagnosia, dysproccia and subtle difficulties.
  • To elicit changes that have occurred recently or after some significant pathology like head injury or encephalitis.
  • To establish areas regarded by the patient as special strengths.
  • To elicit fluctuations in higher brain function e.g. some exceptionally good, other significant impairments.
  • To obtain baseline data ranging from laterality to personality to triggers of symptoms. The SOBIN also includes several other screening areas — the pre-SOBIN historical phenomena depending on complexity., for example, details pertaining to laterality of function, responses to flashing lights. This data is a derivation from the original INSET of which the SOBIN is a spin-off so that it may not be elicited if already listed under the INSET.


BASIS: This test is the only available clinical neuropsychiatric inventory screening for soft organic type symptoms and learning disabilities. It also allows the perspective of comparison data with the past. In the context of patients with questionable organic or brain pathology or neurological conditions with possible psychiatric elements, previous head injury or encephalitis or tumor or other brain insult or possible seizure disorders or paroxsymal neurobehavioral disorders, it is critical to be able to screen in a consistent and standardized manner such symptoms and to ensure that there are no indicators of invalid responses so as to be able to better interpret neuropsychiatric tests properly. 

 

 


Copyright ©1997-2003 Pacific Neuropsychiatric Institute